Last reviewed · How we verify
Vitamin K Deficiency Induced Hypoprothrombinemia
Approved treatments
- phytomenadione · Instituto Mexicano del Seguro Social
- Phylloquinone · Guy's and St Thomas' NHS Foundation Trust
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Vitamin K Deficiency Induced Hypoprothrombinemia patent landscape — cliff calendar, originator estates, attackable patents
- Vitamin K Deficiency Induced Hypoprothrombinemia treatment landscape brief
- Vitamin K Deficiency Induced Hypoprothrombinemia treatment updates RSS
Frequently asked questions about Vitamin K Deficiency Induced Hypoprothrombinemia
What drugs treat Vitamin K Deficiency Induced Hypoprothrombinemia?
Tracked treatments include phytomenadione, Phylloquinone.
What is the treatment for Vitamin K Deficiency Induced Hypoprothrombinemia?
Standard treatment for Vitamin K Deficiency Induced Hypoprothrombinemia includes phytomenadione, Phylloquinone. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Vitamin K Deficiency Induced Hypoprothrombinemia patent cliff · Vitamin K Deficiency Induced Hypoprothrombinemia CI report
- Treatment: phytomenadione · Instituto Mexicano del Seguro Social
- Treatment: Phylloquinone · Guy's and St Thomas' NHS Foundation Trust
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing